EXPANDED TABLE OF CONTENTS
VOLUME 7, NUMBER 12 DECEMBER 2004
|
| TREATMENT HIGHLIGHTS |
| RELAPSE IN ANOREXIA NERVOSA |
| Several cognitive and behavioral variables are found to be associated with relapse in anorexia nervosa. |
| WEIGHT, PHYSICAL ACTIVITY, AND DIABETES |
| Both physical activity and body mass index (BMI) are found to be associated with the development of type 2 diabetes, with BMI having the greater role. |
| ADOLESCENT-ONSET GAMBLING
|
| Adolescent-onset gambling is found to be associated with increased likelihood of depression and substance use problems. |
| LONG-TERM OUTCOME OF ANXIETY TREATMENT IN CHILDREN |
| Cognitive-behavioral therapy of anxiety disorders in youths is found to be associated with long-term improvement in anxiety and with less substance use. |
| COEXISTING MAJOR DEPRESSION AND BORDERLINE PERSONALITY DISORDER |
| Among patients with coexisting major depressive disorder and borderline personality disorder, improvements in depression are predicted by improvements in borderline psychopathology. |
| OF NOTE |
| Validity of Diagnosing ADHD at Ages 4 to 6 Years |
| ETCETERA |
| Nicotine Dependence and Psychiatric Disorders |
| PSYCHOPHARMACOLOGY NOTES |
| TREATMENT OF LATE-LIFE DEPRESSION |
| In the treatment of late-life depression, citalopram is found to be effective only in cases of more severe depression. |
| SEROTONIN REUPTAKE INHIBITION AND THE RISK OF ABNORMAL BLEEDING |
| Serotonin reuptake inhibition is found to be associated with a higher risk of abnormal bleeding. |
| FDA NEWS AND REVIEW |
| Product Safety Information: The Food and Drug Administration has issued a "Questions and Answers" statement in response to regulatory action pertaining to Effexor (venlafaxine) in the United Kingdom. |
| Approval (new drug) of Lunesta (eszopiclone) Tablets. Indication: treatment of insomnia. |
| Approval (new drug) of Equetro (carbamazepine) Extended Release Capsules. Indication: treatment of acute manic and mixed episodes associated with bipolar I disorder. |
| Approval (new indication) of Geodon (ziprasidone hydrochloride) Capsules. New indication: treatment of acute manic and mixed episodes associated with bipolar I disorder. |
| ASSESSMENT |
| Multidimensional Scale of Perceived Social Support (MSPSS) |
| RESOURCES |
| Each issue presents descriptions of clinical resources (eg, professional materials, patient handouts) and information on how to receive those materials. |
